
This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.
The American Journal of Managed Care
almost 25 years ago
TennCare - Medicaid Managed Care in Tennessee in Jeopardyalmost 25 years ago
The Generalist's Patient and the Subspecialistalmost 25 years ago
Issues in Pooling Administrative Data for Economic Evaluation